Clinical Trials Directory

Trials / Completed

CompletedNCT02858219

A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to compare the efficacy of botulinum toxin injections on vestibulodynia pain compared to a group treated with a placebo.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum Toxin Type A
OTHERSaline solution
OTHERIndexesVisual Analogic Scale (VAS), Female Sexual Function Index (FSFI), Dermatology Life Quality Index (DLQI)

Timeline

Start date
2010-05-04
Primary completion
2019-02-11
Completion
2019-02-11
First posted
2016-08-08
Last updated
2022-11-10

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02858219. Inclusion in this directory is not an endorsement.